metyrapone has been researched along with Buerger Disease in 2 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santangelo, ML | 1 |
| Schonauer, M | 1 |
| Corsale, C | 1 |
| Rossi, P | 2 |
| Maglione, S | 1 |
| Aurilia, MG | 1 |
| Marano, E | 1 |
2 other studies available for metyrapone and Buerger Disease
| Article | Year |
|---|---|
[Instrumental study of peripheral circulation in juvenile vascular diseases in conditions of dynamic changes of adrenal cortex activity. II. The Liddle effect].
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Angiography; Blood Circulation; Body Temperature | 1964 |
[Dynamic study of adrenal cortex function in patients with arteriopathy. II. The Liddle test].
Topics: Adrenal Glands; Adult; Glucocorticoids; Humans; Metyrapone; Mineralocorticoids; Pituitary-Adrenal Fu | 1964 |